Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Morgan Stanley's stake in Apellis Pharmaceuticals, Inc. fell below 5% (Schedule 13G/A)
Event May 31, 2026 · Filed Jun 5, 2026
Morgan Stanley's stake in Apellis Pharmaceuticals, Inc. fell below 5%, 0 shares, as a passive investor on May 31, 2026. Filed Jun 5, 2026 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 0% | 0 |
| Morgan Stanley Capital Services LLC | 0% | 0 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Morgan Stanley
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G · Morgan Stanley · Feb 3, 2025
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Schedule 13G/A · Rtw Investments, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026
- Form 4 · Dolsten Mikael · May 14, 2026